首页> 外文期刊>Management International Review >Interaction Between the Business Environment and the Corporate Strategic Positioning of Firms in the Pharmaceutical Industry: A Study of the Entry and Expansion Path of MNEs into China
【24h】

Interaction Between the Business Environment and the Corporate Strategic Positioning of Firms in the Pharmaceutical Industry: A Study of the Entry and Expansion Path of MNEs into China

机译:医药行业企业经营环境与企业战略定位之间的相互作用:跨国公司进入中国和进入中国的路径研究

获取原文
获取原文并翻译 | 示例
       

摘要

This article attempts to examine major factors affecting the entry and expansion paths of MNEs targeting the highly regulated Chinese pharmaceutical industry on the basis of the dynamic interaction between the FSAs of MNEs and CSAs of host countries. The longitudinal analysis of investment patterns of foreign subsidiaries over 1980-1996 demonstrates that Western and Asian NIEs' firms tend to follow a different entry path when facing the same market conditions due to their different FSAs and strategic settings. While the same firms tend to adapt their strategies over time as a result of changing CSAs, the direction of their further expansion is determined by their FSAs.
机译:本文试图在跨国公司的FSA与东道国CSA之间的动态互动的基础上,研究影响针对以高度监管的中国医药行业为目标的跨国公司进入和扩展路径的主要因素。对外国子公司1980-1996年投资模式的纵向分析表明,西方和亚洲NIE的公司由于面临FSA和战略背景的不同,在面对相同的市场条件时倾向于遵循不同的进入路径。虽然相同的公司往往会随着CSA的变化而不断调整其策略,但其进一步扩张的方向却取决于其FSA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号